Cassava Sciences Inc. [SAVA] gain 596.48% so far this year. What now?



Cassava Sciences Inc. [NASDAQ: SAVA] stock went on a downward path that fall over -5.30% on Tuesday, amounting to a one-week price decrease of less than -8.44%. The company report on October 20, 2021 that FILING DEADLINE–Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BMY, EAR, HYZN and SAVA.

The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


Cassava Sciences, Inc. (SAVA)Class Period: September 14, 2020 and August 27, 2021Lead Plaintiff Motion Deadline: October 26, 2021SECURITIES FRAUD To learn more, visit

Over the last 12 months, SAVA stock rose by 382.72%. The average equity rating for SAVA stock is currently 2.00, trading closer to a bullish pattern in the stock market.

The market cap for the stock reached $2.04 billion, with 39.95 million shares outstanding and 37.46 million shares in the current float. Compared to the average trading volume of 8.33M shares, SAVA stock reached a trading volume of 3711020 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Guru’s Opinion on Cassava Sciences Inc. [SAVA]:

Cantor Fitzgerald have made an estimate for Cassava Sciences Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on July 15, 2021. While these analysts kept the previous recommendation, Maxim Group dropped their target price from $80 to $190. The new note on the price target was released on July 07, 2021, representing the official price target for Cassava Sciences Inc. stock. Previously, the target price had yet another raise to $78, while B. Riley Securities analysts kept a Buy rating on SAVA stock. On February 16, 2021, analysts increased their price target for SAVA shares from 20 to 66.

The Average True Range (ATR) for Cassava Sciences Inc. is set at 5.31 The Price to Book ratio for the last quarter was 6.86, with the Price to Cash per share for the same quarter was set at 6.48.

SAVA Stock Performance Analysis:

Cassava Sciences Inc. [SAVA] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -8.44. With this latest performance, SAVA shares dropped by -1.57% in over the last four-week period, additionally plugging by 36.22% over the last 6 months – not to mention a rise of 382.72% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SAVA stock in for the last two-week period is set at 38.73, with the RSI for the last a single of trading hit 34.95, and the three-weeks RSI is set at 40.84 for Cassava Sciences Inc. [SAVA]. The present Moving Average for the last 50 days of trading for this stock 66.90, while it was recorded at 51.14 for the last single week of trading, and 58.98 for the last 200 days.

Insight into Cassava Sciences Inc. Fundamentals:

Return on Total Capital for SAVA is now -19.24, given the latest momentum, and Return on Invested Capital for the company is -11.06. Return on Equity for this stock declined to -11.08, with Return on Assets sitting at -10.76. When it comes to the capital structure of this company, Cassava Sciences Inc. [SAVA] has a Total Debt to Total Equity ratio set at 0.32. Additionally, SAVA Total Debt to Total Capital is recorded at 0.32, with Total Debt to Total Assets ending up at 0.31. Long-Term Debt to Equity for the company is recorded at 0.25, with the Long-Term Debt to Total Capital now at 0.25.

Reflecting on the efficiency of the workforce at the company, Cassava Sciences Inc. [SAVA] managed to generate an average of -$575,818 per employee.Cassava Sciences Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 60.30 and a Current Ratio set at 60.30.

Cassava Sciences Inc. [SAVA] Insider Position Details

There are presently around $516 million, or 27.50% of SAVA stock, in the hands of institutional investors. The top three institutional holders of SAVA stocks are: BLACKROCK INC. with ownership of 2,451,879, which is approximately 1.953% of the company’s market cap and around 1.90% of the total institutional ownership; VANGUARD GROUP INC, holding 1,826,203 shares of the stock with an approximate value of $86.75 million in SAVA stocks shares; and STATE STREET CORP, currently with $41.32 million in SAVA stock with ownership of nearly 26.747% of the company’s market capitalization.

>> 7 Top Picks for the Post-Pandemic Economy <<

Positions in Cassava Sciences Inc. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 120 institutional holders increased their position in Cassava Sciences Inc. [NASDAQ:SAVA] by around 1,857,757 shares. Additionally, 60 investors decreased positions by around 1,619,488 shares, while 11 investors held positions by with 7,376,492 shares. The mentioned changes placed institutional holdings at 10,853,737 shares, according to the latest SEC report filing. SAVA stock had 61 new institutional investments in for a total of 677,536 shares, while 21 institutional investors sold positions of 724,959 shares during the same period.



Download Free eBook For


100% free. stop anytime no spam



Download Free eBook For


100% free. stop anytime no spam